Riskpilot← Back to searchSign inGet full accessTRT Pharma Oy
OYDissolvedY-tunnus 2659698-1Ulvilantie 20-F72Retail sale of cosmetic and toilet articles · NACE 4775Est. 2014— employees
Revenue 2024
EUR 0
EBITDA margin
—
-100% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
EUR -1K
-100% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR 5K | -100% |
| Net profit | EUR -1K | -100% |
| Total assets | EUR 2,6M | -10% |
| Equity | EUR 2,6M | -8% |
| Employees | — | — |
Legal name
TRT Pharma Oy
Y-tunnus number
2659698-1
Legal form
Osakeyhtiö
NACE code
4775 · Retail sale of cosmetic and toilet articles
Founded
10. joulukuuta 2014
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on terveystuotteiden, lääkkeiden käyttöön tarvittavien välineiden ja tarvikkeiden, nikotiinivalmistelden, luontaistuotteiden, elintarvikkeiden ja kosmeettisten valmisteiden ja muiden ns. vapaankaupan tuotteiden vähittäiskauppa, tukkukauppa, valmistus, maahantuonti ja maastavienti. Yhtiön toimialaan kuuluvat myös lääkehoidon tukipaivelut, kosmetologin palvelut, konsultointi -ja koulutuspaivelut ja henkilöstönvuokraus. Lisäksi yhtiön toimialaan kuuluvat kiinteistöjen ja maa-alueiden, osuuksien, osakkeiden ja muiden arvopapereiden ostaminen, hallitseminen ja myyminen.
Address
Ulvilantie 20-F72
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 1 572 | 1 618 | 1 601 | 1 639 | 1 164 | 0 |
| Staff expenses | — | — | — | — | — | — |
| EBITDA | 525 | 546 | 538 | 2 742 | 2 042 | 5 |
| Depreciation & amort. | — | — | — | — | — | — |
| EBIT | 525 | 546 | 538 | 535 | 287 | −5 |
| Net financials | 19 | 24 | 31 | 29 | −0 | 0 |
| Profit before tax | 544 | 571 | 569 | 564 | 372 | −1 |
| Tax | 109 | 114 | 116 | 111 | 73 | −0 |
| Net profit | 435 | 456 | 453 | 453 | 300 | −1 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 2 220 | 2 755 | 3 134 | 3 538 | 2 931 | 2 628 |
| Equity | 1 956 | 2 256 | 2 528 | 2 779 | 2 857 | 2 628 |
| Long-term debt | — | — | — | — | — | — |
| Short-term debt | 264 | 499 | 605 | 759 | 74 | 0 |
| Total debt | 264 | 499 | 605 | 759 | 74 | 0 |
EBITDA margin
453100.0%
This company
15.8%
Market median
+2867622% vs market
20192024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20192024
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20192024
Net profit margin
-123200.0%
This company
8.1%
Market median
-1521088% vs market
20192024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20192024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TJ Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
PJ | Audit | 2015 | — | — |
JB Audit | Audit | 2021 | — | — |
TT Deputy auditor | Deputy auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Chairperson | 2015 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TRT Pharma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tuukka Joel Valtteri Pesonen | Chief Executive Officer | 0 companies |
| Pekka Johannes Neuvonen | Audit | 0 companies |
| Jan-Erik Björklöf | Audit | 0 companies |
| Timo Tapio Post | Deputy auditor | 0 companies |
| Reetta Sini Maaria Kuosmanen | Board of Directors | 0 companies |
| Timo Jyrki Pesonen | Chairperson | 0 companies |